These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 35057536)
1. The Role of the Western Diet and Oral Microbiota in Parkinson's Disease. Zapała B; Stefura T; Milewicz T; Wątor J; Piwowar M; Wójcik-Pędziwiatr M; Doręgowska M; Dudek A; Jania Z; Rudzińska-Bar M Nutrients; 2022 Jan; 14(2):. PubMed ID: 35057536 [TBL] [Abstract][Full Text] [Related]
3. Altered gut microbiota in Parkinson's disease patients/healthy spouses and its association with clinical features. Zhang F; Yue L; Fang X; Wang G; Li C; Sun X; Jia X; Yang J; Song J; Zhang Y; Guo C; Ma G; Sang M; Chen F; Wang P Parkinsonism Relat Disord; 2020 Dec; 81():84-88. PubMed ID: 33099131 [TBL] [Abstract][Full Text] [Related]
4. Alteration of the fecal microbiota in North-Eastern Han Chinese population with sporadic Parkinson's disease. Li F; Wang P; Chen Z; Sui X; Xie X; Zhang J Neurosci Lett; 2019 Aug; 707():134297. PubMed ID: 31200089 [TBL] [Abstract][Full Text] [Related]
5. A Pilot Microbiota Study in Parkinson's Disease Patients versus Control Subjects, and Effects of FTY720 and FTY720-Mitoxy Therapies in Parkinsonian and Multiple System Atrophy Mouse Models. Vidal-Martinez G; Chin B; Camarillo C; Herrera GV; Yang B; Sarosiek I; Perez RG J Parkinsons Dis; 2020; 10(1):185-192. PubMed ID: 31561385 [TBL] [Abstract][Full Text] [Related]
6. The nasal and gut microbiome in Parkinson's disease and idiopathic rapid eye movement sleep behavior disorder. Heintz-Buschart A; Pandey U; Wicke T; Sixel-Döring F; Janzen A; Sittig-Wiegand E; Trenkwalder C; Oertel WH; Mollenhauer B; Wilmes P Mov Disord; 2018 Jan; 33(1):88-98. PubMed ID: 28843021 [TBL] [Abstract][Full Text] [Related]
7. Gut, oral and nasal microbiota and Parkinson's disease. Shen L Microb Cell Fact; 2020 Feb; 19(1):50. PubMed ID: 32103766 [TBL] [Abstract][Full Text] [Related]
8. Oral, Nasal, and Gut Microbiota in Parkinson's Disease. Li Z; Lu G; Luo E; Wu B; Li Z; Guo J; Xia Z; Zheng C; Su Q; Zeng Y; Chan WY; Su X; Qiu X; Zheng X; Cai Q; Xu Y; Chen Y; Fan Y; Chen W; Yu Z; Chen X; Zheng C; Wang M; Poon WS; Luo X Neuroscience; 2022 Jan; 480():65-78. PubMed ID: 34695538 [TBL] [Abstract][Full Text] [Related]
9. The oral microbiome of early stage Parkinson's disease and its relationship with functional measures of motor and non-motor function. Mihaila D; Donegan J; Barns S; LaRocca D; Du Q; Zheng D; Vidal M; Neville C; Uhlig R; Middleton FA PLoS One; 2019; 14(6):e0218252. PubMed ID: 31247001 [TBL] [Abstract][Full Text] [Related]
10. [Features of gut microbiota in patients with idiopathic Parkinson's disease]. Li Y; Li RX; Du YT; Xu XJ; Xue Y; Gao D; Gao T; Sheng Z; Zhang LY; Tuo HZ Zhonghua Yi Xue Za Zhi; 2020 Apr; 100(13):1017-1022. PubMed ID: 32294860 [No Abstract] [Full Text] [Related]
11. Structural changes of gut microbiota in Parkinson's disease and its correlation with clinical features. Li W; Wu X; Hu X; Wang T; Liang S; Duan Y; Jin F; Qin B Sci China Life Sci; 2017 Nov; 60(11):1223-1233. PubMed ID: 28536926 [TBL] [Abstract][Full Text] [Related]
12. Gut microbiota in patients with Parkinson's disease in southern China. Lin A; Zheng W; He Y; Tang W; Wei X; He R; Huang W; Su Y; Huang Y; Zhou H; Xie H Parkinsonism Relat Disord; 2018 Aug; 53():82-88. PubMed ID: 29776865 [TBL] [Abstract][Full Text] [Related]
13. The human oral cavity microbiota composition during acute tonsillitis: a cross-sectional survey. Yeoh YK; Chan MH; Chen Z; Lam EWH; Wong PY; Ngai CM; Chan PKS; Hui M BMC Oral Health; 2019 Dec; 19(1):275. PubMed ID: 31806002 [TBL] [Abstract][Full Text] [Related]
14. Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome. Hill-Burns EM; Debelius JW; Morton JT; Wissemann WT; Lewis MR; Wallen ZD; Peddada SD; Factor SA; Molho E; Zabetian CP; Knight R; Payami H Mov Disord; 2017 May; 32(5):739-749. PubMed ID: 28195358 [TBL] [Abstract][Full Text] [Related]
15. Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression. Aho VTE; Pereira PAB; Voutilainen S; Paulin L; Pekkonen E; Auvinen P; Scheperjans F EBioMedicine; 2019 Jun; 44():691-707. PubMed ID: 31221587 [TBL] [Abstract][Full Text] [Related]
16. Dysbiosis of gut microbiota in a selected population of Parkinson's patients. Pietrucci D; Cerroni R; Unida V; Farcomeni A; Pierantozzi M; Mercuri NB; Biocca S; Stefani A; Desideri A Parkinsonism Relat Disord; 2019 Aug; 65():124-130. PubMed ID: 31174953 [TBL] [Abstract][Full Text] [Related]
17. Altered gut microbiota and inflammatory cytokine responses in patients with Parkinson's disease. Lin CH; Chen CC; Chiang HL; Liou JM; Chang CM; Lu TP; Chuang EY; Tai YC; Cheng C; Lin HY; Wu MS J Neuroinflammation; 2019 Jun; 16(1):129. PubMed ID: 31248424 [TBL] [Abstract][Full Text] [Related]
18. Alterations of oral microbiota in patients with panic disorder. Xie Z; Jiang W; Deng M; Wang W; Xie X; Feng X; Shi Y; Zhang X; Song D; Yuan Z; Wang Y Bioengineered; 2021 Dec; 12(1):9103-9112. PubMed ID: 34666612 [TBL] [Abstract][Full Text] [Related]